Kasra Allaei Rouzbahani - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Clinical and Experimental Medicine|November 17, 2025

PDCD1 as a targetable immune checkpoint hub: therapeutic insights for ibrutinib-resistant CLL managementNiloufar Sadat Kalaki, Elham Karimi, Kasra Allaei Rouzbahani, et al.

Health Science Reports|February 25, 2026

Assessment of Awareness and Knowledge Regarding Human T-Lymphotropic Virus Type 1 (HTLV-1) Among Healthcare Workers at Imam Khomeini Hospital Complex, Tehran, in 2023-2024, A Cross-Sectional Descriptive-Analytical StudyArash Letafati, Yasaman Goudarzi, Mohsen Sheikhi, et al.

Health Science Reports|July 31, 2026

Targeted Interventions in HAM/TSP: Emerging Therapies and Future Directions - A Narrative ReviewMeygol Mirzaei Rezaei, Mahdi Khosravi Nia, Kasra Allaei Rouzbahani, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Clinical and Experimental Medicine|November 17, 2025

PDCD1 as a targetable immune checkpoint hub: therapeutic insights for ibrutinib-resistant CLL managementNiloufar Sadat Kalaki, Elham Karimi, Kasra Allaei Rouzbahani, et al.

Health Science Reports|February 25, 2026

Assessment of Awareness and Knowledge Regarding Human T-Lymphotropic Virus Type 1 (HTLV-1) Among Healthcare Workers at Imam Khomeini Hospital Complex, Tehran, in 2023-2024, A Cross-Sectional Descriptive-Analytical StudyArash Letafati, Yasaman Goudarzi, Mohsen Sheikhi, et al.

Health Science Reports|July 31, 2026

Targeted Interventions in HAM/TSP: Emerging Therapies and Future Directions - A Narrative ReviewMeygol Mirzaei Rezaei, Mahdi Khosravi Nia, Kasra Allaei Rouzbahani, et al.

Pageof 1